Dental Care Clinics in Whiting, NJ Accepting Medicare
2 Dental Care Clinics found. Showing 1 - 2
 Crestwood Family Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 70 Lacey Rd, Whiting, NJ 08759 Phone: 732-350-7999 Fax: 732-350-7961 |
Crestwood Family Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 70 Lacey Rd, Whiting, NJ 08759 Phone: 732-350-7999 Fax: 732-350-7961 |
News Archive
Folic acid can dramatically reduce the incidence of spina bifida and other birth defects
A study, published today in BMC Pregnancy and Childbirth, shows that the proportion of babies born with neural tube defects in the province of Newfoundland and Labrador dropped by 78% after the Canadian Government directed that folic acid must be added to flour, cornmeal and pasta. The study supports the continuation of this food fortification strategy.
UNC-CH awarded $100,000 Grand Challenges Explorations grant for study of ultrasound as a contraceptive
The University of North Carolina at Chapel Hill has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by James Tsuruta, PhD, and Paul Dayton, PhD, titled "Ultrasound as a long-term, reversible contraceptive."
Feinberg physiology professor named recipient of 2015 AES Seed Grant
Today the American Epilepsy Society announced Anis Contractor, Ph.D., Associate Professor of Physiology at Northwestern University, Feinberg School of Medicine, as the recipient of a 2015 AES Seed Grant. Dr. Contractor's proposed research seeks to address a fundamental question about cellular and circuit level excitability in the mouse model of Dravet Syndrome.
Newl workplace safety models
Tools for assisting organizations in their efforts to more accurately calculate, analyze, interpret and communicate the costs and benefits of workplace safety and health programs are featured as part of published proceedings released on July 29th in the National Safety Council's Journal of Safety Research (JSR).
CTI responds to EMA's Day 120 letter for pixantrone MAA
Cell Therapeutics, Inc. today announced that it has submitted its response to the Day 120 List of Outstanding Issues to the European Medicines Agency's Committee for Medicinal Products for Human Use in regards to CTI's Marketing Authorization Application for pixantrone to treat relapsed or refractory aggressive non-Hodgkin's lymphoma.
› Verified 3 days ago